Free Trial

Viracta Therapeutics (VIRX) Insider Trading & Ownership

→ World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad)
Free VIRX Stock Alerts
$0.82
-0.02 (-1.83%)
(As of 01:02 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Viracta Therapeutics (NASDAQ:VIRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.42%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$25,526.06
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$14,599.75
Get VIRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Viracta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VIRX Insider Buying and Selling by Quarter

Ad Traders Agency
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Viracta Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2024Daniel R ChevallardCFOSell3,405$0.73$2,485.65  
11/30/2023Mark RotheraCEOBuy52,094$0.49$25,526.06  
11/28/2023Daniel R ChevallardCFOSell3,720$0.50$1,860.00  
8/28/2023Daniel R ChevallardCFOSell3,512$1.45$5,092.40  
5/25/2023Daniel R ChevallardCFOSell3,635$1.42$5,161.70  
(Data available from 1/1/2013 forward)

VIRX Insider Trading Activity - Frequently Asked Questions

Who is on Viracta Therapeutics's Insider Roster?

The list of insiders at Viracta Therapeutics includes Daniel R Chevallard, Ivor Royston, Lisa Rojkjaer, and Mark Rothera. Learn more on insiders at VIRX.

What percentage of Viracta Therapeutics stock is owned by insiders?

7.42% of Viracta Therapeutics stock is owned by insiders. Learn more on VIRX's insider holdings.

Which Viracta Therapeutics insiders have been buying company stock?

The following insider purchased VIRX shares in the last 24 months: Mark Rothera ($25,526.06).

How much insider buying is happening at Viracta Therapeutics?

Insiders have purchased a total of 52,094 VIRX shares in the last 24 months for a total of $25,526.06 bought.

Which Viracta Therapeutics insiders have been selling company stock?

The following insiders have sold VIRX shares in the last 24 months: Daniel R Chevallard ($51,778.61), Ivor Royston ($78,657.59), and Lisa Rojkjaer ($22,252.10).

How much insider selling is happening at Viracta Therapeutics?

Insiders have sold a total of 63,811 Viracta Therapeutics shares in the last 24 months for a total of $152,688.30 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:VIRX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
He Is Giving Away Bitcoin
Crypto Swap Profits
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group
The only accurate crypto trading system I know …
Weiss Ratings